The FDA released a recent warning concerning lorcaserin, a weight-loss drug. One trial has found that this particular drug may increase the risk of cancer. If you take this drug or consider taking this drug, you’ll likely want to know this information. It was only one trial conducted, so it is unknown if this does increase the risk of cancer. But, it is still kind of concerning.
Lorcaserin, also known as Belviq, is a drug known for quite a long time. It was approved in 2012 to treat obesity or overweight people with at least one weight-related comorbidity. The way Belviq works is it is a selective serotonin 2C receptor agonist. It activates these receptors in the brain, and by doing this promotes sanity or the feeling of fullness, therefore decreasing food intake. Some common side effects that you could experience while taking Belviq include nausea, headache, and fatigue.
The FDA came out with a statement on January 14th concerning the lorcaserin. The statement said that the results from a clinical trial had shown that participants taking this drug did possibly have an increased risk of cancer. It results from only one clinical trial; it did have few people in it but more needs to be done. Because of the limited results, the FDA could not say what causes increased cancer risk. At this time, the cause of the cancer is uncertain, and we cannot conclude that lorcaserin contributes to the cancer risk.
Lorcaserin increased any risk of cardiovascular complications such as chest pain, heart attack, etc.; for those taking the drug, don’t freak up just yet. The FDA has not made any definite conclusion. There are billions of people in the world, so one trial of twelve thousand people isn’t enough. However, you do need to consider this information. With this new possibility of increased cancer risk, you need to ask yourself if the benefit of treatment still outweigh the risk. It is what the health care and you need to decide before continuing treatment with lorcaserin.
Therefore, it’s suggested to take some precautions before using Lorcaserin. Before taking this supplement, be certain to think about some medication precautions and contraindications. Some users may be allergic to the ingredients used in Lorcaserin. Pregnant and breastfeeding women should not take this supplement as it can affect the infant. Lorcaserin can also interact with prescription and non-prescription drugs. It’s contraindicated to cancer patients or people susceptible to it.